Genetic modification of xenografts.
For nearly a century, xenotransplantation has been seen as a potential approach to replacing organs and tissues damaged by disease. Until recently, however, the application of xenotransplantation has seemed only a remote possibility. What has changed this perspective is the advent of genetic engineering of large animals; that is, the ability to add genes to and remove genes from lines of animals that could provide an enduring source of tissues and organs for clinical application. Genetic engineering could address the immunologic, physiologic and infectious barriers to xenotransplantation, and could allow xenotransplantation to provide a source of cells with defined and even controlled expression of exogenous genes. This communication will consider one perspective on the application of genetic engineering in xenotransplantation.
Platt
J L
JL
Transplantation Biology, Department of Surgery, Medical Sciences Building 2-66, Mayo Clinic, 200 1st Street S.W., Rochester, MN 55905, USA. Platt.jeffrey@mayo.edu
D000818:Animals; D000941:Antigens / Q000235:genetics; D005818:Genetic Engineering; D006084:Graft Rejection; D006801:Humans; D014183:Transplantation, Heterologous / Q000276:immunology
D000941:Antigens